Cronos Group Inc.

NASDAQ:CRON

Drug Manufacturers - Specialty & Generic

Healthcare
$3.17 -0.56%

-$0.02 today

Market cap
$1.16B
Beta
1.25
P/E (TTM)
-488.3
EPS (TTM)
-$0.01
52W Low $1.84High $3.43

Volume 1.13M

Average 1.51M

CRON Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

Cronos Group Inc.NASDAQ: CRON

Net Debt · Q1 FY2026 · quarter ended Mar 2026

Net debt remains negative

Q1 FY2026 net debt was -$823.24M, compared with -$796M a year earlier.

Context

  • Net debt amounted to 70.0% of total assets at the end of Q1 FY2026, up 1.0 pp from a year earlier.
  • Net debt grew in size in 1 of the last 3 fiscal years.

What to watch

Whether net debt keeps falling in the next quarterly balance sheet after a -3.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$823.24M-4.2% QoQ
Last fiscal yearDec 2025
-$790.29M+7.8% YoY
Year agoMar 2025
-$796M-3.4% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.4%——
1 year+7.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2025
(790.29M) USD
Year-over-year change
+7.8%

Net Debt vs competitors

How CRON compares with its peers on the latest reported figures

  • CRON's Mar 2026 net debt of -$823.24M is the lowest of the 11 companies compared; the peer median is $2.97M.
  • Its year-over-year change of -3.4% is the 2nd highest of 11, against a peer median of -26.1%.
  • Net debt amounts to 70.0% of total assets for CRON, versus a peer median of 26.7%.
CRON Competitors Peer median
Net Debt for CRON and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
EMBCEmbecta Corp.Mar 2026$1.17B -12.6%-2.8%113.9%
COLLCollegium Pharmaceutical, Inc.Mar 2026$539.41M -27.9%+8.8%32.7%
AMPHAmphastar Pharmaceuticals, Inc.Mar 2026$515.2M +9.7%—31.3%
PCRXPacira BioSciences, Inc.Mar 2026$266.87M -24.4%-23.4%22.1%
XNCRXencor, Inc.Jun 2026$20.55M -12.5%+186.4%2.8%
PHATPhathom Pharmaceuticals, Inc.Mar 2026-$14.6M -104.1%—4.8%
BBOTBridgeBio Oncology Therapeutics Inc.Mar 2026-$50.01M -112.2%—12.0%
IRMDIRadimed CorporationMar 2026-$56.37M -12.1%—49.3%
RAPPRapport Therapeutics, Inc. Common StockMar 2026-$67.25M -35.1%—13.5%
NRIXNurix Therapeutics, Inc.Aug 2026-$654.91M -2883.4%—54.8%
CRONCronos Group Inc.Mar 2026-$823.24M -3.4%—70.0%
Peer median (excluding CRON) $2.97M-26.1%+3.0%26.7%

Competitors are the stored peer set for CRON. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents886.97M764.64M669.29M858.81M791.79M
Short-term Investments117.68M113.08M192.24M040M
Net Receivables33.29M31.29M35.88M29.77M57.2M
Inventory32.8M37.56M30.5M33.15M46.75M
Other Current Assets07.11M5.41M14.39M8.34M
Total Current Assets1.08B960.16M933.31M936.11M944.09M
Property, Plant & Equipment (Net)82.95M62.83M60.82M134.58M147.29M
Goodwill1.1M1.03M1.06M63.45M66.48M
Intangible Assets18.08M26.7M21.08M11.13M8.89M
Long-term Investments135.16M89.75M54.74M2.81M7.66M
Tax Assets00226K2.57M1.89M
Other Non-current Assets80.74M72.54M69.04M15.53M20.85M
Total Non-current Assets318.02M252.85M206.96M230.07M253.05M
Total Assets1.4B1.21B1.14B1.17B1.2B
Account Payables11.11M11.16M12.13M16.97M11.64M
Short-term Debt00000
Tax Payables3.59M37.09M11.76M11.84M0
Deferred Revenue00000
Other Current Liabilities14.38M15K102K40K20.11M
Total Current Liabilities54.37M68.12M41.4M49.7M48.19M
Long-term Debt00000
Deferred Tax Liabilities81K0181K3.56M4.09M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.91M1.38M1M1.07M733K
Total Non-current Liabilities9.09M3.93M2.74M5.63M5.99M
Total Liabilities63.46M72.05M44.14M55.33M54.18M
Common Stock595.5M611.32M662.17M669.88M661.78M
Retained Earnings659.42M490.68M416.72M457.71M447.76M
Accumulated OCI49.87M(797K)20.68M(63.53M)(16.84M)
Other Stockholders Equity00(48.45M)00
Minority Interest(2.97M)(2.92M)(3.45M)46.92M49.06M
Total Equity1.33B1.14B1.1B1.11B1.14B
Total Debt9.81M3.88M2.55M2.02M1.51M
Net Debt(877.17M)(760.77M)(666.74M)(856.79M)(790.29M)

Cronos Group Inc.

NASDAQ:CRON

Intrinsic Alpha fair value

Locked

Current Price

$3.17

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.